Listerin promotes α-synuclein degradation to alleviate Parkinson’s disease through the ESCRT pathway
Science Advances · 14.02.2025 · 11 (7)
DOI: 10.1126/sciadv.adp3672 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 14.02.2025. Verfasst von Fei Qin und 16 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Infection, Immunity and prevention of Shandong Province & Key Laboratory for Experimental Teratology of Ministry of Education, Shan…. Hauptthemen laut MEDLINE: Parkinson Disease, alpha-Synuclein, Endosomal Sorting Complexes Required for Transport, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the progressive accumulation of abnormal α-synuclein (α-syn) within dopaminergic neurons in the substantia nigra region of the brain. Despite excessive accumulation of α-syn being key to the pathogenesis of PD, the mechanisms governing its clearance remain elusive. In this study, we found that the endosomal sorting complex required for transport (ESCRT) system plays a crucial role in capturing and facilitating the degradation of ubiquitinated α-syn. The E3 ubiquitin ligase Listerin was found to promote K27-linked polyubiquitination of α-syn, directing it to the endosome for subsequent degradation. We showed that the deletion of the Listerin gene exacerbates the neurodegenerative progression in a mouse model of PD, whereas the overexpression of Listerin effectively mitigates disease progression in PD mice. Consequently, our study reveals a mechanism for α-syn degradation and identifies Listerin as a promising therapeutic target for the treatment of PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Infection, Immunity and prevention of Shandong Province & Key Laboratory for Experimental Teratology of Ministry of Education, Shandong University, Jinan, Shandong 250012, P.R. China.
- Department of Immunology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong 250012, P.R. China.
- Department of Pathogenic Biology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong 250012, P.R. China.
ORCID-Profile: Fei Qin, Runyu Cao, Xuemei Bai, Feng Liu, Yi Zheng, Wei Zhao, Bingyu Liu, Chengjiang Gao
Zitieren
APA
Qin, F., Cao, R., Cui, W., Bai, X., Yuan, J., Zhang, Y., Liu, Y., Cao, N., Dong, N., Zhou, M., Chen, T., Liu, F., Sun, W., Zheng, Y., Zhao, W., Liu, B., & Gao, C. (2025). Listerin promotes α-synuclein degradation to alleviate Parkinson’s disease through the ESCRT pathway. Science Advances, 11(7). https://doi.org/10.1126/sciadv.adp3672
Vancouver
Qin F, Cao R, Cui W, Bai X, Yuan J, Zhang Y, et al. Listerin promotes α-synuclein degradation to alleviate Parkinson’s disease through the ESCRT pathway. Science Advances. 2025;11(7). doi:10.1126/sciadv.adp3672
BibTeX
@article{Qin2025,
author = {Qin, Fei and Cao, Runyu and Cui, Wenjing and Bai, Xuemei and Yuan, Jiahua and Zhang, Yuling and Liu, Yaxing and Cao, Nan and Dong, Na and Zhou, Min and Chen, Tian and Liu, Feng and Sun, Wanwei and Zheng, Yi and Zhao, Wei and Liu, Bingyu and Gao, Chengjiang},
title = {Listerin promotes α-synuclein degradation to alleviate Parkinson’s disease through the ESCRT pathway},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {7},
doi = {10.1126/sciadv.adp3672}
}
EUVIMED